Status:
WITHDRAWN
Cardiopulmonary Interactions in Patients With Heart Failure
Lead Sponsor:
Hannover Medical School
Conditions:
Heart Failure
Pulmonary Hypertension
Eligibility:
All Genders
40+ years
Brief Summary
This study aims to evaluate cardiopulmonary interactions in patients with heat failure
Detailed Description
Heart failure is one of the most common diseases, especially in ageing populations, affecting ≥10% of persons 70 years of age or older. There is a growing body of evidence that dyspnea in patients wit...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Written informed consent prior to initiation of any study-mandated procedures
- Male or female ≥40 years at screening
- Confirmed diagnosis of HFpEF (Heart failure with preserved ejection fraction), HFmrEF (heart failure with mid range ejection fraction) or HFrEF (Heart failure with reduced ejection fraction) in New York Heart Association (NYHA) Functional Class II, III or IV
- Exclusion criteria
- Significant lung disease according to the judgment of the investigator; as a rule, the total lung capacity (TLC) should be \>70% of the predicted value and the forced expiratory volume in 1 second (FEV1) should be \>60% of the predicted value
- Significant co-morbidities expected to limit life expectancy to less than 2 years, according to the judgment of the investigator
Exclusion
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03317314
Start Date
July 1 2017
End Date
December 31 2017
Last Update
May 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hannover MS
Hanover, Lower Saxony, Germany